Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Aside from share price ... smells right for some bolt-ons

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jan 16, 2023 9:39am

81 Views

Post# 35225348

RE:RE:RE:RE:Aside from share price ... smells right for some bolt-ons

These aliases have been telling the same bs loosing story for 10 Years while GUD dropped from $10 to $5 and stuck there now for many Years. The only reason GUD share price is above $5 is because GUD is the buyers with money from the PP and not from the profits as they have had none.
Is GUD stops buying its share the stock price will drop below $2 its real value
The defination of madness is when you keep saying the same bs story over and over again and expect different resuls

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario